15 reports

Heart Attack Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Heart Attack
  • APAC
  • World
  • Market Size
  • Advance its product pipeline through increased investment in R&D activities
  • PROJECTED PREVALENCE OF CVDS IN US

Out of this, ##, ## are affected by heart attack for the first time and ##, ## people have already had a heart attack.

  • Heart Attack
  • AstraZeneca PLC
  • Novartis AG
  • NSTEMI group
  • Pfizer Inc.
  • 5.1 CARDIOVASCULAR TESTING

The ideal AMI marker is one that has high clinical sensitivity and specificity, appears soon after the onset of a heart attack; remains elevated for several days following a heart attack and can be assayed with a rapid turnaround time.

  • Heart Attack
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Boditech Med Inc.
  • Untitled
  • Untitled

HEART ATTACK PRODUCT OVERVIEW TABLE ##: MARKET CATEGORY DIAGNOSTIC TEST - HEART ATTACK - PRODUCT STATUS IN VITRO DIAGNOSTICS--> IMMUNO CHEMISTRY--> IMMUNOCHEMISTRY RAPID TESTS & POC--> CARDIAC MARKERS RAPID TESTS & POC TABLE ##: TECHNOLOGY DIAGNOSTIC

  • Clinical Trial
  • Diagnostics
  • Heart Attack
  • Molecular Diagnostics
  • bioMerieux S.A.

SCAD is the number one cause of heart attacks in young women## and the average age is ##.

  • Heart Attack
  • Heart Failure
  • United States
  • Product Initiative
  • Abiomed, Inc.
  • PIPELINE BY DALCOR PHARMACEUTICALS INC, H2 2019

THE MOLECULES DEVELOPED BY COMPANIES IN PHASE III, PHASE II, PRECLINICAL AND DISCOVERY STAGES ARE ##, ##, ## AND ## RESPECTIVELY.

  • Cardiology
  • Heart Attack
  • Hospital
  • Pharmaceutical
  • Pfizer Inc.

(Inactive) ## ## ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## Abbott Laboratories Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2018 2018 trials are taken as of December 2018 ##

  • Heart Attack
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • DIAGNOSTIC BLOOD TEST - HEART ATTACK - PRODUCT STATUS
  • DIAGNOSTIC BLOOD TEST - HEART ATTACK - PRODUCT DESCRIPTION

Patients suspected of suffering a heart attack will often be given a troponin test to aide diagnosis, but until now the test has not been used to assess future heart attack risk.

  • Clinical Trial
  • Diagnostics
  • Heart Attack
  • United States
  • Company
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Cardiovascular Disease
  • Heart Attack
  • World
  • Product Initiative
  • Aurobindo Pharma Limited

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiology
  • Clinical Trial
  • Heart Attack
  • Hospital
  • World
  • MIRACOR MEDICAL SYSTEMS GMBH COMPANY SNAPSHOT
  • RECENT DEVELOPMENTS

THE MIRACOR PICSO® IMPULSE SYSTEM IS DESIGNED TO TREAT ACUTE HEART ATTACK STEMI PATIENTS AND LESS SEVERE NSTEMI HEART ATTACK PATIENTS IN COMPLEMENT WITH PERCUTANEOUS CORONARY INTERVENTION (PCI, OR CORONARY ANGIOPLASTY).

  • Heart Attack
  • United Kingdom
  • United States
  • Product Initiative
  • NSTEMI group

## ## ## ## ## ## Pfizer Inc Stealth BioTherapeutics Inc Prolong Pharmaceuticals LLC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Minapharm Pharmaceuticals & Chemical Industries ## ## ## ## ## ## ## Merck & Co Inc ## ##

  • Heart Attack
  • Monoclonal Antibody
  • Pharmaceutical
  • World
  • Product Initiative
  • JUN 01, 2015: NEUROVIVE REPORTS TOPLINE RESULTS OF PHASE III CIRCUS STUDY IN ACUTE MYOCARDIAL INFARCTION
  • MAY 25, 2015: NEUROVIVE PHARMACEUTICAL: TOPLINE RESULT OF PHASE III STUDY OF CICLOMULSION IN ACUTE MYOCARDIAL INFARCTION EXPECTED THIS QUARTER

RESEARCH INTO CICLOMULSION S EFFICACY BEYOND THE TREATMENT OF REPERFUSION INJURY FOLLOWING HEART ATTACK GREW OUT OF THE CONCEPT OF MITOCHONDRIAL PROTECTION IN CONNECTION WITH ORGAN INJURY FOCUSING ON HEART DISEASE.

  • Heart Attack
  • Therapy
  • World
  • Product Initiative
  • CicloMulsion AG

They are coming in with a heart attack.

  • Heart Attack
  • Therapy
  • United States
  • Product Initiative
  • Abbott Vascular, Inc.

At the heart of Vereos is a state-of-the-art detector that converts detected photons directly into digital information.

  • Diagnostic Imaging
  • Heart Attack
  • Hospital
  • Company
  • Product Initiative